Document ID: CL-WP-002 | Rev A | Author: Michael Pitsakis | Advisors: Dr. Ralf Marbach & Dr. Robert Norwood
BEYOND GLUCOSE: The Next Era of Non-Invasive Diagnostics
For decades, non-invasive optical diagnostics have been constrained to basic cardiopulmonary tracking, like heart rate and oxygen saturation, while viewing continuous glucose monitoring as the ultimate, yet elusive, finish line. CoraLuma’s recent white paper, Beyond Glucose: Continuous Multi-Analyte and Hemodynamic Profiling Through Pulsatile Vis-SWIR Spectroscopy, challenges this limitation. The paper details how the CCE 1 platform utilizes a patent-pending 6-3-9 transverse optical geometry to physically isolate the pulsatile arterial waveform. By coupling this hardware with redundant fiducial anchoring and a mathematically rigorous Matérn 5/2 Gaussian Process Regression (GPR) pipeline, CoraLuma’s technology goes far beyond simple empirical ratioing. This advanced computational biophotonics architecture opens a robust diagnostic pathway capable of decoupling weak molecular overtones from massive physiological noise, effectively extracting high-resolution data on metabolic markers, renal function, continuous NIBP, and exogenous intoxicants—all from a single, non-invasive optical stream.
For full article 02_CL-WP-002-RevA_Beyold_Glucose.pdf, click link below.